SYNEOS HEALTH UK LIMITED

SkyQuest projects the Clinical Trials Market to reach USD 102.12 Billion by 2031, with a CAGR of 8.7% from 2024-2031, driven by rising chronic diseases and personalized therapies.

Franco, a clinical trial participant, faces organ inflammation from experimental medication, highlighting issues in Canada's clinical trial industry where participants, often economically desperate, are incentivized to lie about side effects to complete studies for full payment. Canada leads G7 nations in clinical trials per capita but lacks robust oversight, fostering a subculture of deception among participants. Health Canada aims to align with international best practices by 2025, but current oversight is limited, with only a fraction of trials inspected annually. Participants like Franco, lured by high compensation, often conceal health issues and side effects, risking their health and compromising study data integrity.

Battery Management Solution IC manufacturers significantly impact the market by driving advancements in battery technology, enhancing efficiency, safety, and reliability. Key growth drivers include the increasing adoption of electric vehicles, portable electronics, and renewable energy systems. Opportunities lie in the expanding EV market and renewable energy projects. Challenges include high development costs, rapid technological advancements, and stringent regulatory requirements.

The Oncology Clinical Trial Market is projected to grow from USD xx.x Billion in 2023 to USD xx.x Billion by 2031, driven by increasing cancer prevalence, technological advancements, and regulatory support. Key manufacturers include IQVIA, Charles River Laboratory, ICON Plc, and others. Challenges include regulatory complexities and high costs. Opportunities exist in real-world evidence and novel trial designs.

The global cell and gene therapy clinical trials market was valued at USD 11.62 billion in 2023 and is projected to reach USD 47.40 billion by 2033, growing at a CAGR of 15.09%. Factors driving growth include a favorable regulatory environment, increasing interest in cancer treatments, patient demand for innovative therapies, and rising R&D funding. North America leads with a 49.76% share, while Asia Pacific is expected to grow fastest at a CAGR of 15.7%. The oncology segment dominates with a 49.1% share.

CytoDyn Inc. (CYDY) reports significant 2024 progress, including FDA lifting leronlimab's clinical hold, submitting two trial protocols, settling with Amarex for $10 million, and initiating pre-clinical/clinical trials. Focus areas include oncology (colorectal cancer, triple-negative breast cancer, glioblastoma) and inflammation (HIV-related chronic inflammation, Alzheimer's Disease, chronic fatigue syndrome). The company believes it has sufficient cash to advance development into 2025.

The global RNA Therapy Clinical Trials Market is projected to reach $3.32 billion by 2031, driven by mRNA-based COVID-19 vaccines and increasing investments in RNA therapeutics. Challenges include efficient RNA delivery and IP protection. North America leads in market share due to robust research infrastructure and government support.

Syneos Health is seeking a Clinical Trial Associate in Amsterdam West to support project teams within the Clinical Development Centre (CDC) in The Netherlands for assigned clinical trials. Responsibilities include preparation, execution, and finalisation of clinical trials, ensuring timely project deliverables of required quality. The role involves oversight of trial documentation, maintenance of Sponsor Trial Master File (STMF), and collaboration with project teams. Qualifications include previous clinical trial experience, knowledge of Good Clinical Practice/ICH guidelines, strong organizational skills, proficiency with MS Office Applications, and fluency in Dutch and English. The position offers career development, a supportive culture, and the opportunity to work in a competitive, ever-changing environment.

Syneos Health is hiring a Senior Clinical Trial Manager to oversee site management, monitoring, and ensure patient safety, protocol compliance, and data integrity. The role involves strategic thinking, risk mitigation, and collaboration with various functional teams. Requirements include a bachelor's degree, leadership skills, and expertise in site management and monitoring, with potential for 20% travel.